Results
|
26221.
|
|
|
26222.
|
Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). [electronic resource] by
- Patel, Jai N
- Jiang, Chen
- Hertz, Daniel L
- Mulkey, Flora A
- Owzar, Kouros
- Halabi, Susan
- Ratain, Mark J
- Friedman, Paula N
- Small, Eric J
- Carducci, Michael A
- Mahoney, John F
- Kelley, Michael J
- Morris, Michael J
- Kelly, William K
- McLeod, Howard L
Producer: 20150522
In:
Cancer vol. 121
Availability: No items available.
|
|
26223.
|
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients. [electronic resource] by
- Spreafico, Anna
- Chi, Kim N
- Sridhar, Srikala S
- Smith, David C
- Carducci, Michael A
- Kavsak, Peter
- Wong, Tracy S
- Wang, Lisa
- Ivy, S Percy
- Mukherjee, Som Dave
- Kollmannsberger, Christian K
- Sukhai, Mahadeo A
- Takebe, Naoko
- Kamel-Reid, Suzanne
- Siu, Lillian L
- Hotte, Sebastien J
Producer: 20150609
In:
Investigational new drugs vol. 32
Availability: No items available.
|
|
26224.
|
Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity. [electronic resource] by
- Zhang, Lisa J
- Xiong, Yin
- Nilubol, Naris
- He, Mei
- Bommareddi, Swaroop
- Zhu, Xuguang
- Jia, Li
- Xiao, Zhen
- Park, Jeong-Won
- Xu, Xia
- Patel, Dhaval
- Willingham, Mark C
- Cheng, Sheue-Yann
- Kebebew, Electron
Producer: 20150617
In:
Carcinogenesis vol. 36
Availability: No items available.
|
|
26225.
|
PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer. [electronic resource] by
- Kirschner, Austin N
- Wang, Jie
- van der Meer, Riet
- Anderson, Philip D
- Franco-Coronel, Omar E
- Kushner, Max H
- Everett, Joel H
- Hameed, Omar
- Keeton, Erika K
- Ahdesmaki, Miika
- Grosskurth, Shaun E
- Huszar, Dennis
- Abdulkadir, Sarki A
Producer: 20150219
In:
Journal of the National Cancer Institute vol. 107
Availability: No items available.
|
|
26226.
|
|
|
26227.
|
Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2. [electronic resource] by
- Mukhopadhyay, N K
- Kim, J
- You, S
- Morello, M
- Hager, M H
- Huang, W-C
- Ramachandran, A
- Yang, J
- Cinar, B
- Rubin, M A
- Adam, R M
- Oesterreich, S
- Di Vizio, D
- Freeman, M R
Producer: 20140904
In:
Oncogene vol. 33
Availability: No items available.
|
|
26228.
|
|
|
26229.
|
|
|
26230.
|
|
|
26231.
|
|
|
26232.
|
Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5. [electronic resource] by
- Al-Jameel, Waseem
- Gou, Xiaojun
- Forootan, Shiva S
- Al Fayi, Majed Saad
- Rudland, Philip S
- Forootan, Farzad S
- Zhang, Jiacheng
- Cornford, Philip A
- Hussain, Syed A
- Ke, Youqiang
Producer: 20180326
In:
Oncotarget vol. 8
Availability: No items available.
|
|
26233.
|
|
|
26234.
|
Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer. [electronic resource] by
- Qiao, Yuanyuan
- Feng, Felix Y
- Wang, Yugang
- Cao, Xuhong
- Han, Sumin
- Wilder-Romans, Kari
- Navone, Nora M
- Logothetis, Christopher
- Taichman, Russell S
- Keller, Evan T
- Palapattu, Ganesh S
- Alva, Ajjai S
- Smith, David C
- Tomlins, Scott A
- Chinnaiyan, Arul M
- Morgan, Todd M
Producer: 20161020
In:
Neoplasia (New York, N.Y.) vol. 18
Availability: No items available.
|
|
26235.
|
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy. [electronic resource] by
- Hertz, Daniel L
- Owzar, Kouros
- Lessans, Sherrie
- Wing, Claudia
- Jiang, Chen
- Kelly, William Kevin
- Patel, Jai
- Halabi, Susan
- Furukawa, Yoichi
- Wheeler, Heather E
- Sibley, Alexander B
- Lassiter, Cameron
- Weisman, Lois
- Watson, Dorothy
- Krens, Stefanie D
- Mulkey, Flora
- Renn, Cynthia L
- Small, Eric J
- Febbo, Phillip G
- Shterev, Ivo
- Kroetz, Deanna L
- Friedman, Paula N
- Mahoney, John F
- Carducci, Michael A
- Kelley, Michael J
- Nakamura, Yusuke
- Kubo, Michiaki
- Dorsey, Susan G
- Dolan, M Eileen
- Morris, Michael J
- Ratain, Mark J
- McLeod, Howard L
Producer: 20180105
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22
Availability: No items available.
|
|
26236.
|
|
|
26237.
|
|
|
26238.
|
|
|
26239.
|
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial. [electronic resource] by
- Noguchi, Masanori
- Arai, Gaku
- Egawa, Shin
- Ohyama, Chikara
- Naito, Seiji
- Matsumoto, Kazumasa
- Uemura, Hirotsugu
- Nakagawa, Masayuki
- Nasu, Yasutomo
- Eto, Masatoshi
- Suekane, Shigetaka
- Sasada, Tetsuro
- Shichijo, Shigeki
- Yamada, Akira
- Kakuma, Tatsuyuki
- Itoh, Kyogo
Producer: 20200508
In:
Cancer immunology, immunotherapy : CII vol. 69
Availability: No items available.
|
|
26240.
|
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA). [electronic resource] by
- Kapoor, Roche
- Deek, Matthew P
- McIntyre, Riley
- Raman, Natasha
- Kummerlowe, Megan
- Chen, Iyah
- Gaver, Matt
- Wang, Hao
- Denmeade, Sam
- Lotan, Tamara
- Paller, Channing
- Markowski, Mark
- Carducci, Michael
- Eisenberger, Mario
- Beer, Tomasz M
- Song, Daniel Y
- DeWeese, Theodore L
- Hearn, Jason W
- Greco, Stephen
- DeVille, Curtiland
- Desai, Neil B
- Heath, Elisabeth I
- Liauw, Stanley
- Spratt, Daniel E
- Hung, Arthur Y
- Antonarakis, Emmanuel S
- Tran, Phuoc T
Producer: 20191223
In:
BMC cancer vol. 19
Availability: No items available.
|